Photo of Morgan Cheatham, Investor

Morgan Cheatham

Investor

Morgan Cheatham is an investor in the New York City office where he focuses on applications of artificial intelligence in healthcare, marketplaces, and enterprise software.

Before joining Bessemer, Morgan worked at Goldman Sachs in the Consumer Retail and Healthcare Group in the Investment Banking Division. He also worked as a data scientist at Kyruus, a healthcare IT startup focused on patient access and provider data management, and as an analyst at Rhode Island’s Health Information Exchange.

Morgan was accepted to medical school at age 17 and graduated magna cum laude from Brown University with a degree in neuroeconomics.

Companies

Abridge

Abridge

Abridge records the details of your care and helps you stay on top of your health, one conversation at a time.

Aspen RxHealth

Aspen RxHealth

Aspen RxHealth is the leader in next-generation clinical pharmacy services, intelligently matching pharmacists with patients.

Clearing

Clearing

Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States.

Folx Health

Folx Health

Folx Health is a digital health provider designed with the medical needs and goals of the LGBTQIA+ community in mind.

Ginger

Ginger

Ginger is an on-demand mental health company that brings together behavioral health coaches, therapists, and psychiatrists, who work as a team to deliver personalized care, right through your smartphone.

Hinge Health

Hinge Health

Hinge Health pioneers the world’s most patient-centered digital hospital, starting with musculoskeletal health.

productboard

productboard

productboard is the product management system that helps organizations get the right products to market, faster.

Qventus

Qventus

Qventus optimizes decisions in hospitals in real time to reduce costs, improve quality and experience.

Subtle Medical

Subtle Medical

Subtle Medical uses AI to redefine the standards for medical imaging, making it faster, safer, and smarter.

Insights from Atlas